Injective has completed the migration of its INJ token from Ethereum's ERC-20 standard to its native Injective EVM blockchain, with Coinbase supporting a seamless 1:1 token conversion. This move enhances access to decentralized finance (DeFi) applications and improves liquidity for users by enabling direct trading on the native network. The migration aligns with Injective's strategic growth, including partnerships like Robinhood, potentially increasing user engagement and institutional interest. While risks exist in technological transitions, this upgrade positions Injective to strengthen its presence in the competitive DeFi space.
Injective, a Layer 1 blockchain focused on finance, has launched Injective Mint, a no-code platform enabling institutions to issue compliant tokenized real-world assets. The platform integrates key compliance features like holder restrictions and jur...
Injective has filed for registration as a transfer agent with the U.S. Securities and Exchange Commission (SEC). This move aims to bring securities ownership records onto a blockchain platform, enhancing transparency and security. By digitizing owner...
Injective announced multiple major initiatives at its Washington D.C. Summit, including the listing of its INJ token on Robinhood Crypto, making it accessible to millions of U.S. users. The token started trading around $4.76-$5, with a market cap nea...
